• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Aemetis Inc. (DE) filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    2/18/26 8:38:48 PM ET
    $AMTX
    Major Chemicals
    Industrials
    Get the next $AMTX alert in real time by email
    amtx20260206c_8k.htm
    false 0000738214 0000738214 2026-02-18 2026-02-18
    --12-31
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): February 18, 2026
     
    Aemetis, Inc.
    Exact name of registrant as specified in its charter
     
    Delaware
    001-36475
    26-1407544
    State or other jurisdiction of incorporation
    Commission File Number
    IRS Employer Identification Number
     
    20400 Stevens Creek Blvd., Suite 700
    Cupertino, CA 95014
    (408) 213-0940
    Registrant's address and telephone number of principal executive office
     
    N/A
    Former name or former address, if changed since last report
     
    Common Stock, par value $0.001
    AMTX
    NASDAQ Global Market
    Title of class of registered securities Trading Symbol Name of exchange on which registered
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
     
    ☐
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter)
     
     
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
     
     

     
     
    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
     
    On February 18, 2026, Aemetis, Inc. (the "Company") filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company's capital stock from 145,000,000 shares to 205,000,000 shares, which reflects the increase in the number of authorized shares of the Company’s common stock, par value $0.001 per share (the "Common Stock"), from 80,000,000 to 140,000,000 shares. A copy of the Certificate of Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
     
    Item 5.07  Submission of Matters to a Vote of Security Holders.
     
    The Company held a Special Meeting of Stockholders on February 18, 2026. The following proposals were voted on by the Company's stockholders, with the results set forth for each proposal:
     
    Proposal 1:  Decrease of Authorized Preferred Stock
     
    For
    Against
    Abstain
    Broker Non-Votes
    26,150,519
    1,265,702
    76,173 13,444,173
     
    The amendment to the Company's Certificate of Incorporation to decrease the number of authorized shares of preferred stock, par value $0.001, from 65,000,000 to 5,000,000 shares has not been approved by the requisite vote of the Company's stockholders.
     
    Proposal 2:  Increase of Authorized Common Stock
     
    For
    Against
    Abstain
    Broker Non-Votes
    35,827,828 4,952,652 156,087
    0
     
    The amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock, par value $0.001, from 80,000,000 to 140,000,000 has been approved by the requisite vote of the Company's stockholders.
     
    Proposal 3:  Adjourn the Special Meeting
     
    For
    Against
    Abstain
    Broker Non-Votes
    36,981,214 3,536,067 419,286
    0
     
    The proposal to provide the Company with discretion to adjourn the Special Meeting to a later date for further solicitation and voting of proxies if there are not sufficient votes to approve Proposal 1 or Proposal 2 has been approved by the requisite vote of the Company's stockholders.
     
    Item 8.01 Other Events.
     
    The Company is filing this Current Report on Form 8-K to provide an updated description of the Company’s capital stock as set forth in Exhibit 99.1 hereto and incorporated by reference herein. The updated description of the Company’s capital stock modifies and supersedes any prior description of the Company’s capital stock in any registration statement filed with the Securities and Exchange Commission (the “Commission”) and will be available for incorporation by reference into certain of the Company’s filings with the Commission pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, including registration statements.
     
    The Company is also providing a legal opinion of its counsel, Allen Overy Shearman Sterling US LLP, regarding the legality of the shares of the Common Stock having an aggregate offering price of up to $210,000,000 (the “Placement Shares”) that may be offered and sold from time to time through H.C. Wainwright & Co., LLC pursuant to the At Market Issuance Sales Agreement, dated January 26, 2021, as amended.
     
    The Placement Shares will be issued pursuant to the Company’s Registration Statement on Form S-3 (Registration No. 333-281457), as amended from time to time (the “Registration Statement”). The legal opinion is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated by reference into the Registration Statement. 
     
    This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
     
    Item 9.01 Financial Statements and Exhibits.
     
    (d) Exhibits.
     
    Exhibit No.
    Description
    3.1
    Certificate of Amendment to the Certificate of Incorporation of Aemetis, Inc.
    5.1
    Opinion of Allen Overy Shearman Sterling US LLP
    23.1
    Consent of Allen Overy Shearman Sterling US LLP (included in Exhibit 5.1)
    99.1 Description of Capital Stock
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document).
     
    SIGNATURE
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
     
      Aemetis, Inc.
       
       February 19, 2026
    /s/ Eric A. McAfee
     
    Eric A. McAfee
     
    Chairman and Chief Executive Officer
     
     
     
     
    Get the next $AMTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTX

    DatePrice TargetRatingAnalyst
    8/16/2023$2.50 → $10.50Neutral → Buy
    UBS
    2/28/2023$3.00Underweight
    Piper Sandler
    12/14/2022$4.25Neutral
    UBS
    8/9/2022$12.00Buy → Hold
    Truist
    11/22/2021$31.00 → $35.00Outperform
    Credit Suisse
    8/23/2021$40.00 → $31.00Outperform
    Credit Suisse
    7/15/2021$25.00Outperform
    Evercore ISI Group
    More analyst ratings

    $AMTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simon Timothy Alan was granted 12,000 shares, increasing direct ownership by 30% to 52,632 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:08:09 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Director Block John R was granted 12,000 shares, increasing direct ownership by 35% to 46,330 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:07:34 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Director Barton Francis P was granted 18,000 shares, increasing direct ownership by 9% to 226,518 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:06:59 PM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    SEC Filings

    View All

    Aemetis Inc. (DE) filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    2/18/26 8:38:48 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Inc. (DE) filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    2/6/26 4:51:52 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form DEFA14A filed by Aemetis Inc. (DE)

    DEFA14A - AEMETIS, INC (0000738214) (Filer)

    1/28/26 4:42:34 PM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aemetis India Subsidiary Begins Biodiesel Deliveries Under $24 Million Allocation from OMCs

    CUPERTINO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX), a diversified renewable natural gas and biofuels company, announced that its Universal Biofuels subsidiary in India secured allocations of approximately $24 million for the supply of more than 27 million liters of biodiesel to India's three government-owned Oil Marketing Companies (OMCs) for the period ending March 2026. Additional OMC fuel supply orders are expected throughout the year to support the India government's goal of increasing from a 1% biodiesel blend to a targeted 5%, as stated in the current India National Policy on Biofuels. "Universal Biofuels and other biodiesel producers look forward to c

    2/3/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Receives Funds from the Sale of $17 million of Federal Clean Energy Tax Credits

    CUPERTINO, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable liquid fuels company focused on lower cost and reduced emissions products, today announced that its Aemetis Biogas LLC subsidiary received funds from the sale of $17 million of federal clean energy tax credits, including a Section 45Z Clean Fuel Production Credit (PTC) and a Section 48 Investment Tax Credit (ITC). The transaction included approximately $12 million for a Section 48 ITC generated from the construction of a dairy manure digester that produces biogas and approximately $5 million from a Section 45Z PTC generated from renewable natural gas production during 20

    12/30/25 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Receives Authority to Construct Air Permits for MVR Project at California Ethanol Plant

    CUPERTINO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and biofuels company, announced today that the Authority To Construct air permits have been issued by the San Joaquin Valley Air Pollution Control District for the mechanical vapor recompression (MVR) energy efficiency project at the Aemetis 65 million gallon per year ethanol plant in Keyes, California. The MVR project is expected to increase cash flow from operations at the Keyes ethanol plant by $32 million per year after the completion of construction in mid-2026 from energy cost reductions, increased income from Low Carbon Fuel Standard credits, and an increase in transferable Sec

    12/2/25 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aemetis upgraded by UBS with a new price target

    UBS upgraded Aemetis from Neutral to Buy and set a new price target of $10.50 from $2.50 previously

    8/16/23 8:55:59 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on Aemetis with a new price target

    Piper Sandler initiated coverage of Aemetis with a rating of Underweight and set a new price target of $3.00

    2/28/23 6:17:45 AM ET
    $AMTX
    Major Chemicals
    Industrials

    UBS initiated coverage on Aemetis with a new price target

    UBS initiated coverage of Aemetis with a rating of Neutral and set a new price target of $4.25

    12/14/22 7:31:59 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Financials

    Live finance-specific insights

    View All

    Aemetis to Review Third Quarter 2025 Financial Results on November 6, 2025

    CUPERTINO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its third quarter 2025 earnings report: Date: Thursday, November 6, 2025 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 188767  Live Participant Dial In (International): +1-973-528-0011 entry code 188767 Webcast URL: https://www.webcaster5.com/Webcast/Page/2211/53150 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Calls, along w

    10/31/25 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Reports Second Quarter 2025 Financial Results

    Revenue increased $9.3M from the first quarter of 2025 to $52.2M, driven by the restart of India biodiesel deliveries under new order from Oil Marketing Companies.Aemetis Biogas recognized $3.1M in revenue from 11 digesters; CARB approved 7 new LCFS pathways in Q2.Signed $27M agreement with NPL to construct H₂S and compression units for 15 dairy digesters.Operating loss improved by $4.9M from the first quarter of 2025, reflecting reduced SG&A in the second quarter of 2025; net loss flat from the second quarter of 2024 after adjusting for one-time items.Appointed new CFO with IPO experience for our India subsidiary. The India subsidiary is targeting a public listing in early 2026.

    8/7/25 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Second Quarter 2025 Financial Results on August 7, 2025

    CUPERTINO, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its second quarter 2025 earnings report: Date: Thursday, August 7, 2025 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 655740 Live Participant Dial In (International): +1-973-528-0011 entry code 655740 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/52764 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Calls, along with

    8/1/25 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/14/24 4:19:02 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/14/24 2:54:17 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/13/24 6:50:28 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Leadership Updates

    Live Leadership Updates

    View All

    Aemetis Appoints J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary

    CUPERTINO, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, has appointed J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary, effective immediately. Mr. Rockett brings over 28 years of relevant experience to the company. Prior to joining Aemetis, he was Vice President, General Counsel, and Corporate Secretary of InEnTec Inc., a developer of technology and facilities to convert waste into renewable fuels and chemical products. Mr. Rockett was formerly an attorney at the law firm of Pillsbury Winthrop Shaw Pittman L

    8/28/23 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Appoints Former California Public Utilities Commissioner Timothy Simon to the Aemetis Board of Directors

    CUPERTINO, CA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas (RNG) and renewable fuels company focused on negative carbon intensity products, today announced the appointment of Timothy Alan Simon, Esq., former Commissioner of the California Public Utilities Commission (CPUC), to the Company's Board of Directors, effective October 14.  Mr. Simon was appointed to the CPUC by Governor Arnold Schwarzenegger in February 2007, ending his term in December 2012. During his time as a CPUC commissioner, Mr. Simon served as Chair of the National Association of Regulatory Utility Commissioners ("NARUC") Natural Gas Committee; Chair of the

    10/18/21 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Indonesia Energy Corporation Announces Appointment of Michael L. Peterson to Board of Directors

    Experienced energy industry and finance executive to serve as Chairman of IEC's Audit Committee JAKARTA, INDONESIA AND DANVILLE, CA / ACCESSWIRE / January 25, 2021 / Indonesia Energy Corporation (NYSE American:INDO) ("IEC"), an oil and gas exploration and production company focused on Indonesia, today announced that the company's Board of Directors has appointed Michael L. Peterson to the Board. Mr. Peterson will serve as an independent Board member and will also serve as the Chairman of the Audit Committee of the Board of Directors. Mr. Peterson has over 30 years of experience in executive management positions in all aspects of the energy industry and finance industries, having served as

    1/25/21 9:00:00 AM ET
    $PED
    $MEDS
    $INDO
    Oil & Gas Production
    Energy
    Other Pharmaceuticals
    Health Care